TC-WYRE: TAXUS Express Stent vs. Cypher Stent - What's Your Real Life Experience?

This study has been completed.

First Received: June 23, 2006 Last Updated: October 7, 2008 History of Changes

Sponsored by:	Boston Scientific Corporation
Information provided by:	Boston Scientific Corporation
ClinicalTrials.gov Identifier:	NCT00344630

Purpose

To compare the relative efficacy and safety of the TAXUS Express2 stents and the Cypher stents among a broad, unselected patient population treated in a nationwide, multi-center clinical registry representative of 'real-world,' contemporary clinical practice. A secondary objective is to examine performance of the two stents in pre-specified subgroup populations and examine regional and national patterns in outcomes.

Condition	Intervention
Coronary Artery Disease	Device: TAXUS Stent and Cypher Stent

Study Type:	Interventional
Study Design:	Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study
Official Title:	TC-WYRE: TAXUS Express Stent vs. Cypher Stent - What's Your Real Life Experience?

Resource links provided by NLM:

MedlinePlus related topics: Coronary Artery Disease

U.S. FDA Resources

Further study details as provided by Boston Scientific Corporation:

Estimated Enrollment:	2500
Study Start Date:	May 2006
Estimated Study Completion Date:	June 2006

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Patients treated with a TAXUS Express2 stent or a Cypher stent between April 1, 2005 and June 30, 2005.

Exclusion Criteria:

Simultaneous treatment with both TAXUS and Cypher stents during the index revascularization. Patients who have undergone previous target vessel(s), stenting procedure within 9 months of the index procedure will be excluded.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00344630

Locations

United States, North Carolina
Duke University
Durham, North Carolina, United States, 27710

Sponsors and Collaborators

Boston Scientific Corporation

Investigators

Principal Investigator:

William O'Neill, MD

Duke University

More Information

No publications provided

Study ID Numbers:	S5572, BSC
Study First Received:	June 23, 2006
Last Updated:	October 7, 2008
ClinicalTrials.gov Identifier:	NCT00344630 History of Changes
Health Authority:	United States: Food and Drug Administration

Study placed in the following topic categories:

Arterial Occlusive Diseases
Coronary Disease
Heart Diseases
Myocardial Ischemia

Vascular Diseases
Arteriosclerosis
Ischemia
Coronary Artery Disease

Additional relevant MeSH terms:

Arterial Occlusive Diseases
Coronary Disease
Heart Diseases
Myocardial Ischemia

Vascular Diseases
Cardiovascular Diseases
Arteriosclerosis
Coronary Artery Disease

ClinicalTrials.gov processed this record on September 11, 2009